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 Angelman Syndrome (AS) is a severe neurological disorder characterized by mental 
retardation, motor dysfunction and epilepsy. We now show that the molecular and 
cellular deficits of an AS mouse model can be rescued by introducing an 
additional mutation at the inhibitory phosphorylation site of αCaMKII. Moreover, 
these double mutants do no longer show the behavioral deficits seen in AS mice, 
suggesting that these deficits are the direct result of increased αCaMKII inhibitory 
phosphorylation. 
  
Angelman Syndrome (AS) is caused by loss of function of imprinted genes on human 
chromosome 15q11-13 or by mutations in the UBE3A gene which resides in this region1-4. 
Imprinting of this gene results in exclusive maternal expression in hippocampal neurons and 
cerebellar Purkinje cells5. The UBE3A gene encodes E6-AP, a ubiquitin protein ligase, but its 
role remains elusive. Heterozygous mice with a maternally inherited Ube3a mutation (from 
here on designated as AS mice) exhibit seizures, motor and cognitive abnormalities similar to 
the symptoms seen in AS patients6. Biochemical analysis of these mice indicates a reduction 
of calcium/calmodulin-dependent kinase type 2 (CaMKII) activity, and increased 
phosphorylation of the inhibitory Thr305 and Thr306 site7. Because increased CaMKII 
inhibitory phosphorylation has a severe impact on neuronal function8-10, we now investigated 
whether the increased inhibitory CaMKII phosphorylation is directly responsible for the 
major deficits seen in AS. Female AS mice were crossed with heterozygous males that carry 
the targeted αCaMKII-T305V/T306A mutation, which prevents αCaMKII inhibitory 
phosphorylation (designated as CaMKII-305/6+/– mice) (Supplementary methods). This 
resulted in offspring with four different genotypes: wild-type (WT) mice, mutants carrying 
the AS mutation or αCaMKII-305/6+/– mutation, and mice carrying the double AS/CaMKII-
305/6+/– mutation. As shown previously7,  Western blot analysis of hippocampal lysates, 
showed a significant increase of Thr305 phosphorylation in AS mice (130%; P<0.05 Fisher’s 
PLSD). In contrast, inhibitory phosphorylation was significantly reduced in CaMKII-305/6+/– 
mutants (40%, P<0.001), and remained at this low level in AS/CaMKII-305/6+/– double 
mutants (Fig. 1a and Supplementary Fig.1). Moreover, the decreased kinase activity of the 
AS mutants was restored to near wild-type levels in the AS/CaMKII-305/6+/– double mutants 
(Fig. 1b). Thus, these mutants are suitable to test to what extend increased CaMKII 
inhibitory phosphorylation is underlying the neurological phenotype of AS mice.  
All mutants appeared healthy, but adult (> 2 months) AS mice showed a small (20%) 
but significant increase in bodyweight (P<0.005 Fisher’s PLSD; Supplementary Fig. 2). 
Although obesity is not a characteristic feature of the disease, it has been reported in 15% of 
all AS children11 and in the majority of AS children carrying the Ube3a mutation12. 
Moreover, obesity is common feature of children with a previously unrecognized form of 
AS13. Notably, increased bodyweight was absent in AS/CaMKII-305/6+/– double mutants 
(P>0.3). Since αCaMKII expression is restricted to neurons, these results suggest that the 
increased bodyweight of AS mice has a neurological basis, and is caused by increased 
αCaMKII Thr305/306 phosphorylation.  
Epilepsy is a common feature of AS11,14. However, since epilepsy is absent in some 
AS patients and background-dependent in AS mice8, several genes seem to be involved in the 
development of this phenotype. Nevertheless, since reduced αCaMKII activity can result in 
epilepsy8, it could potentially contribute to the increased seizure propensity of AS mice. 
Using audiogenic stimulation, we observed seizures in 50% of the AS mice, whereas no 
seizures were observed in WT mice or CaMKII-305/6+/– mutants. Notably, there was a 3 fold 
reduction of seizure propensity in AS/CaMKII-305/6+/– double mutants as compared to the 
AS mutants (P<0.05 Pearson’s test, Fig. 1c). This suggests that the increased CaMKII 
inhibitory phosphorylation strongly contributes to the increased seizure susceptibility of the 
AS mutants.  
Motor coordination deficits are common in all AS patients and AS mice6,14. The 
UBE3A gene is imprinted in cerebellar Purkinje cells5 and we have previously shown that 
αCaMKII is essential for cerebellar motor learning and Purkinje cell plasticity15. Therefore, 
these deficits could well be caused by deregulation of cerebellar CaMKII. Motor 
performance of the mutants was assessed using an accelerating rotarod. Indeed there was a 
significant effect of genotype (F3,31=6.9, P<0.005 repeated measures ANOVA): AS mice 
stayed significantly shorter on the rotarod compared to their wild-type littermates (P<0.0001 
Fisher’s PLSD; Fig.1d). In contrast, CaMKII-305/6+/– mutants performed better than wild-
type mice (P<0.005) whereas AS/CaMKII-305/6+/– mice were normal (WT versus 
AS/CaMKII-305/6+/–: P=0.5). These results suggest that regulation of CaMKII inhibitory 
phosphorylation plays a critical role in motor coordination performance and that the 
increased CaMKII inhibitory phosphorylation directly underlies the motor performance 
deficits of AS mice. 
The UBE3A gene is also imprinted in the hippocampus5. The critical role of 
αCaMKII in hippocampus-dependent learning8 makes it likely that the increased inhibitory 
phosphorylation of αCaMKII underlies the cognitive deficits in AS patients and AS mice6. 
Hippocampal-dependent learning was first assessed using the Morris watermaze task. A 
probe trial given after 6 days of training revealed a significant effect of genotype when the 
number of target platform crossings was compared between mutants (F3,66=3.7, P<0.05 
ANOVA). Indeed, whereas WT and CaMKII-305/6+/– mutants showed significant more 
crossings of the target platform position as compared to the other positions, AS mice did not 
(WT P<0.0001; CaMKII-305/6+/– P<0.0001; AS P=0.16, Paired t-test between target and 
average of other positions)(Fig 2a,b). The learning deficit of AS mutants was not due to 
impaired motor performance or decreased motivation to escape, since all mutants showed 
similar escape latencies in the hidden platform task (F3,31=0.8, P=0.5 repeated measures 
ANOVA, Fig 2c) as well as in the visible platform task (Supplementary Fig. 3). Moreover, 
swim speed of AS mice was similar as wild-type mice, and the spatial learning deficits were 
overcome by additional training (Supplementary Fig. 3). Importantly, the spatial learning 
deficits of AS mice at day 6, were again completely rescued by the CaMKII-305/6+/– 
mutation, since the AS/CaMKII-305/6+/– double mutants showed a highly selective search 
strategy (target crossing versus average of other positions P<0.0001, Paired t-test). 
Hippocampal-dependent learning was also assessed using contextual fear 
conditioning. Context-dependent memory was tested 24 hours or 7 days following training 
(Fig 2d). A significant effect of genotype was observed at both time points with AS mice 
freezing significantly less than any other group (24 hours: F3,25= 9, P<0.0005 ANOVA all 
P<0.01 Fisher’s PLSD; 7 days: F3,25= 26, P<0.0001 ANOVA; all P<0.0001 Fisher’s PLSD). 
In contrast, CaMKII-305/6+/– mutants showed significantly more freezing in the 7 days 
memory test (all P<0.05 Fisher’s PLSD) but not in the 24 hours memory test. Once more, the 
phenotype was rescued by the AS/CaMKII-305/6+/– double mutation (WT versus 
AS/CaMKII-305/6+/– 24 hours: P=0.6; 7 days: P=0.4 Fisher’s PLSD). Since cued 
conditioning was normal in the AS mice (Supplementary Fig. 4), we conclude that AS mice 
have a hippocampal learning deficit, and that this deficit can be rescued by decreasing 
αCaMKII inhibitory phosphorylation. 
αCaMKII inhibitory phosphorylation plays an important role in setting the threshold 
for the induction of long-term potentiation (LTP): homozygous CaMKII-305/6 mice show 
increased LTP at sub-threshold stimulation, and normal LTP when a strong stimulation 
protocol is applied9. Conversely, AS mice show a striking LTP deficit, which is rescued by a 
strong stimulation protocol6,7. To directly test whether the LTP deficit of AS mice is due to 
excessive Thr305/306 phosphorylation, we measured LTP in hippocampal slices of the mutants. 
Consistent with previous findings, AS mice showed a severe LTP deficit compared to wild-
type mice (F3,87=0.3, P<0.0001 ANOVA; all P<0.001 Fishers PLSD)(Fig. 2e). However, 
LTP was normal in the CaMKII-305/6+/– mice (P=0.5 Fishers PLSD) as well as in the 
AS/CaMKII-305/6+/– double mutants (P=0.4 Fishers PLSD), suggesting that the plasticity 
deficits of AS mice are the result of increased CaMKII inhibitory phosphorylation. 
Although further research is needed to link E6-AP to CaMKII inhibitory 
phosphorylation, this is the first study to report a functional connection between CaMKII and 
a human learning and memory disorder. It also represents a fundamental breakthrough in our 
basic understanding of the molecular basis of the motor, seizure and cognitive facets 
observed in Angelman syndrome.  
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Figure 1. Reduction of αCaMKII inhibitory phosphorylation rescues CaMKII 
activity, seizure propensity and motor performance deficits associated with AS. (a) CaMKII 
Thr305 phosphorylation is reduced in hippocampal lysates of AS/CaMKII-305/6+/– double 
mutants (b) Restoration of CaMKII activity in hippocampal synaptosomes of AS/CaMKII-
305/6+/– double mutants. (c) Propensity to audiogenic seizures of AS mutants is reduced in 
AS /CaMKII-305/6+/– double mutants. (d) Opposing effects of the AS mutation and CaMKII-
305/6+/– mutation on performance on the accelerating rotarod. Asterisks indicate significant 
differences from wild-type mice. Error bars represent s.e.m. All animal experiments were 
approved by the Dutch Ethical Committee, or in accordance with Institutional Animal Care 
and Use Committee guidelines. See text and Supplementary methods for statistics, 
experimental details and number of subjects used. 
 
Figure 2. Hippocampal learning and plasticity of AS mice is rescued by the CaMKII-305/6+/– 
mutation. (a-c) Learning in the Morris watermaze. (a) A probe trial shows that AS mice 
search less focussed for the platform as compared to WT and CaMKII-305/6+/– mice. The 
plots are a visual representation of all search tracks combined, in which the colour indicates 
the mean time spent at a certain position. The black circle indicates the target platform 
position used during training. The other (virtual) positions are indicated in white. (b) 
Quantification of the platform positions as indicated in (a). Bars represent target position, 
adjacent right, opposite, adjacent left position respectively. Asterisks indicate that target 
position crossing is significantly more than crossing of the other positions. (c) Escape latency 
to reach the platform shows no difference between the mutants. (d) AS mutants show 
impaired contextual conditioning. Freezing was assessed either 24 hours, or 7 days after 
conditioning. (e) LTP deficits of AS mice are rescued by the CaMKII-305/6+/– mutation. 
Error bars represent s.e.m. See text and Supplementary methods for statistics, experimental 
details and number of subjects used. 
Supplementary Figure 1 
 
Decreased inhibitory phosphorylation in hippocampal lysates of AS/CaMKII-305/6+/– double 
mutants. AS mice show a significantly increased CaMKII-T305 phosphorylation, as 
compared to their WT littermates, which is decreased when crossed with CaMKII-305/6+/– 
mice. Western blots were first probed with antibodies directed against Thr305-αCaMKII and 
after stripping re-probed with αCaMKII and Actin. To ensure that the staining was within the 
linear range, the wild-type samples were also loaded at a two fold higher concentration.  
 
Supplementary Figure 2 
The increased bodyweight in AS mice returns to WT level in AS/CaMKII-305/6+/– mice. AS 
mice show a small but significant (P<0.005) increase in bodyweight (females (2.5 months 
old): F3,48=5.6, P<0.005, males (4 months old): F3,13 =9.6, P<0.005 ANOVA; Post hoc 
analysis: all P< 0.005 Fisher’s PLSD), which was absent in AS/CaMKII-305/6+/– double 
mutants (P>0.3 for males and females). Error bars represent s.e.m. 
 
 
Supplementary Figure 3 
Learning of the hidden platform (a-e) and visible (f) platform watermaze. 
AS mice show impaired hippocampal learning at the probe trial given at day 6 compared to 
their wild type littermates, which is improved after two additional training days. (a) During 
the probe trial at day 6 AS mice do not spent significantly more time in the target quadrant as 
compared to all the other quadrants, whereas the AS/CaMKII-305/6+/– mice show high 
preference for the target quadrant. (b) The learning impairment of the AS mice cannot be 
ascribed to motor impairments or motivational problems, as they swim as fast as their wild 
type littermates. Only the CaMKII-305/6+/– mice tend to swim faster. (c,d,e) At the probe trial 
given at day 8, the AS mice caught up with their littermate controls and showed selective 
searching as judged from the time spend in target quadrant (d) and from the number of 
platform crosses (e). To exclude that AS mice have visual or motivational problems that 
could account for the impaired learning, a visible watermaze was performed and the escape 
latency was determined. This task shows no effect of genotype (F3,14=1.4, P=0.3 repeated 
measures ANOVA). Error bars represent s.e.m. 
 
Supplementary Figure 4 
AS mice show no deficits in cued conditioning. Cued conditioning test was used to assess 
whether the contextual conditioning phenotype of the AS mice was hippocampus-dependent. 
Cued conditioning did not reveal any difference between the different mutants, indicating 
that the contextual phenotype found in AS mice is indeed hippocampus-dependent (F3,34 
=0.6, P=0.6 repeated measures ANOVA). Error bars represent s.e.m. 
 
 
Material and Methods  
Breeding of mutants. 
Mutants with the Ube3a null mutation (designated as AS mice) and mutants carrying the 
targeted αCaMKII-T305V/T306A mutation which prevents phosphorylation at these residues 
(designated as CaMKII-305/6+/– mice) were developed as described previously1,2. All 
experiments described in this paper were carried out using hybrid mice in the mixed 129/Sv-
C57BL/6 background. To that end, male αCaMKII-305/6+/– mutants in the C57BL/6 
background were crossed with female AS mutants in the 129/Sv background (weight, 
rotarod, watermaze) or with female AS mutants in the 129/Sv-C57BL/6 background 
(epilepsy, fear conditioning, LTP).  
Mice were genotyped when they were 7-10 days, but the experimenter remained blind 
for the genotype during data collection and the initial analysis. Genotypes were again 
established after all experiments were done and the code was then broken to perform the final 
statistical analysis. All experiments were done with 2-4 month old littermates that were 
housed in groups of 2-3 per homecage. Genotype groups were approximately sex and age 
matched. Single-housed mice were excluded for the behavioral studies. The mice were kept 
on a 12h light/dark cycle, with food and water available ad libitum. The behavioral 
experiments were performed during the light period of the cycle. All animal experiments 
were approved by the Dutch Ethical Committee, or in accordance with guidelines of 
Institutional Animal Care and Use Committee of Vanderbilt University. 
 
Western blot analysis of the phosphorylation state of CaMKII.  
Lysates were prepared by quickly dissecting the hippocampus followed by homogenization 
in lysis buffer (10mM TRIS-HCl 6.8, 2.5% SDS, 2mM EDTA and protease and phosphatase 
inhibitor cocktails (Sigma)). Lysates were then adjusted to 1 mg/ml, and 10 µg was used for 
SDS-PAGE analysis and Western blotting. Western blots were first probed with antibodies 
directed against Thr305-αCaMKII (pB602, 1:5000) and after stripping re-probed with 
αCaMKII (MAB3119, 1:10000; Chemicon), and Actin (MAB1501R, 1:2000; Chemicon). 
Blots were quantified using NIH-Image using the αCaMKII signal as loading control, and 
normalized against wild-type. The number of mice used: WT (4); AS (4); CaMKII-306/5+/– 
(4); AS/CaMKII-305/6+/– (4).  
 
 
CaMKII Activity Measurement 
Mice were sacrificed by cervical dislocation and hippocampi were quickly isolated in ice-
cold cutting solution and sonicated in cold homogenization buffer containing 4 mM HEPES, 
320 mM sucrose and protease inhibitor cocktail (Sigma, Saint Louis, MO). The homogenates 
were centrifuged at 1500 g for 10 min. The supernatant was then centrifuged at 16000 g for 
20 min to yield a pellet containing the crude synaptosome fraction. This fraction was 
resuspended in 200µl homogenization buffer to measure the Ca2+/calmodulin dependent 
CaMKII activity using the assay kit from Millipore Inc. (14-217). The number of mice used: 
WT (6); AS (6); CaMKII-306/5+/– (6); AS/CaMKII-305/6+/– (6).  
 
 
Weight and seizure susceptibility 
Female AS mice started to show increased bodyweight after 2 months, whereas male AS 
mice started to become significantly heavier after 4 months.  Number of mice used: females 
(8-9 weeks): WT (13); AS (7); CaMKII-305/6+/– (10); AS/CAMKII-305/6+/–, (13). Males 
(16-18 weeks): WT (4); AS (3); CaMKII-305/6+/– (6); AS/CaMKII-305/6+/– (4). To assess 
seizure susceptibility we induced audiogenic seizures by vigorously scratching scissors 
across the metal grating of the mouse cage lid for 20 seconds, or shorter if a seizure 
developed before that time. The number of mice used in this paradigm: WT (11); AS (10); 
CaMKII-305/6+/– (12); AS/CaMKII-305/6+/– (15). 
 
Motor performance.  
We tested motor function in F1 mice using the accelerating rotarod (4-40 rpm, in 5 minutes; 
model 7650, Ugo Basile Biological Research Apparatus, Varese, Italy). Mice were given two 
trials per day with a 45-60 min inter trial interval for 4 consecutive days.  For each day we 
calculated the average of the time spent on the rotarod, or of the time until the mouse made 3 
consecutive rotations on the rotarod. Maximum duration of a trial was 5 min. The number of 
mice used: WT (10); AS (7); CaMKII-305/6+/–  (10); AS/CaMKII-305/6+/– (8). 
 
Water Maze.  
To test spatial memory we used the Water Maze. Prior to the test mice were handled 
extensively (2 min/day; 5 days). Our pool is 1.2 m in diameter and has an 11 cm diameter 
platform submerged 1 cm below the water surface. The water is painted milk-white with non-
toxic paint and water temperature is kept constant at 26°C. We use dimmed lighting, and 
mouse-tracking is performed using SMART version 2.0 (Panlab, Barcelona, Spain). Mice 
were given 2 trials per day, with 30 sec inter trial interval for 8 consecutive days. At a 
training session, the mouse was first placed on the platform for 30 sec.  Then it was placed in 
the water at a pseudo-random start position and it was given a maximum of 60 seconds to 
find the platform. If the mouse did not find the platform within 60 seconds, it was placed 
back on the platform. After 30 seconds on the platform, this training procedure was repeated 
once more. The platform position remained at the same position during all trials. 
One hour after the training on day 6 and day 8, a probe trial was given to test spatial 
learning. Mice were placed on the platform for 30 seconds, after which the platform was 
removed from the pool and the mice were placed in the pool at the opposite side of the 
previous platform position. The mice were then allowed to search for the platform for 60 
seconds. The number of mice used for this paradigm: WT (18); AS (11); CaMKII-306/5+/– 
(18); AS/CaMKII-305/6+/– (14).  
The visible water maze was performed done in the same way as the hidden platform 
water maze, except that this time the platform was flagged with a small cue on top the 
platform. The number of (naïve) mice used for this paradigm: WT (6); AS (5); CaMKII-
306/5+/– (4); AS/CaMKII-305/6+/– (3).  
 
 
 
Fear Conditioning.   
Fear conditioning was performed in a testing chamber (26 × 22 × 18 cm; San Diego 
Instruments, San Diego, CA) made of Plexiglas equipped with a grid floor via which the foot 
shock could be administered and a CCD camera to monitor activity. The conditioning 
chamber was placed inside a soundproof isolation cubicle. Training and testing occurred in 
the presence of white light and white noise. Each mouse was placed inside the conditioning 
chamber for 150 seconds before the onset of a 2 s foot shock (0.5 mA). After 150 seconds, a 
second foot shock was delivered, and the mouse was returned to its home cage after another 
2.5 min. Testing of context-dependent fear was performed either 24 hours or 1 week after the 
conditioning in the same context. 
For cued conditioning, each mouse was placed inside the conditioning chamber for 2 
min before the onset of a conditioned stimulus (CS; an 85 dB tone), which lasted for 30 s. 
training occurred in the presence of white light and white noise. A 2 s US foot shock (0.5 
mA) was delivered immediately after the termination of the CS. Each mouse remained in the 
chamber for an additional 120 s, followed by another CS–US pairing. Each mouse was 
returned to its home cage after another 2.5 min. Cued fear conditioning was tested in the 
presence of a masked context consisting of a small Plexiglas cube attached to an opaque 
Plexiglas floor insert, different lighting conditions, and a vanilla odor. Each mouse was 
placed in this novel context for 3 min at approximately 24 h after training, and they were 
exposed to the CS for another 3 min. 
Freezing behavior was recorded and processed by SDI Photobeam Activity System 
software throughout each testing session. The mouse was considered to be freezing after a 
lack of movement for 2 s.  Number of animals used: 24 hours context: WT (6); AS (6); 
CaMKII-305/6+/– (8); AS/CaMKII-305/6+/– (9) ; 1 week context: (WT (7); AS (8); CaMKII-
305/6+/– (7); AS/CaMKII-305/6+/– (8).  24 hours cued: WT (11); AS (11); CaMKII-305/6+/– 
(7); AS/CaMKII-305/6+/– (9) ; 
Shock threshold was assessed by placing the animal in the conditioning chamber and 
by delivering foot shocks starting at 0.075 mA and increasing by 0.05 mA every 30 s. The 
experiment was terminated at the shock intensity sufficient to induce vocalization. There was 
no difference in shock sensitivity between the groups (F3,75=0.53, P=0.9 ANOVA). 
 
 
  
Hippocampal slice preparation and electrophysiology 
The brain was quickly removed and placed in ice-cold high sucrose cutting solution 
containing (in mM): 110 sucrose, 60 NaCl, 3 KCl, 28 NaHCO3, 1.25 NaH2PO4, 7 MgCl2, 0.5 
CaCl2, 0.6 sodium ascorbate, and 5 D- glucose, pH 7.3–7.4. Horizontal 400 µm sections were 
cut in sucrose cutting solution using a Vibratome. The slices were stored in 95% O2/5% CO2-
equilibrated artificial CSF containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 28 
NaHCO3, 1.0 MgCl2, 2.0 CaCl2, and 10 D- glucose, (pH 7.3-7.4) and kept at room 
temperature for at least 1 hour before switching to the interface chamber supported by a 
nylon mesh and allowed to recover for a minimum of 1 hour prior to recording. The chamber 
was kept at 32 ± 0.5 °C with a laminar ACSF flow rate of 2–3 ml/min. Extracellular field 
recordings were obtained from area CA1 of the stratum radiatum. Stimulations were supplied 
with a bipolar Teflon-coated platinum electrode and recordings were obtained with the use of 
a glass microelectrode field with ACSF with tip diameter about 1 µm (1–4 MΩ electrical 
resistance). Tetani used to evoke CA1 LTP consisted of two trains of 100 Hz stimulation for 
1s with each train separated by a 20s interval. Stimulus intensities were adjusted to give 
pEPSPs (population excitatory postsynaptic potentials) with slopes that were <50% of the 
maximum determined from an input/output curve. Potentiation was measured as the 
normalized increase of the mean pEPSP for the duration of the baseline recording. 
Experimental results were obtained from those slices that exhibited stable baseline synaptic 
transmission for a minimum of 30 min prior to the delivery of the LTP- inducing stimulus. 
For recording we used an Axon 1320 Digidata data acquisition hardware operated by Axon 
pClamp 9.2 software. We used maximally two slices per mouse. The number of slices used 
for the experiment are: WT (11); AS (6); CaMKII-305/6+/– (6); AS/CaMKII-305/6+/– (6). 
 
Statistical analysis.  
StatView data analysis software was used for statistical analysis. An ANOVA or repeated 
measures ANOVA was used for multiple group data, to test for the effect of genotype. If this 
was significant, the data was further analyzed using the Fisher PLSD Post Hoc test. All figure 
data represents mean ±SEM. An analysis with a value of p<0.05 was considered to be 
statistically significant (indicated by an asterisk in the figures).  
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